Cargando…
Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy
Microvesicle (MV) release from tumour cells influences drug retention, contributing to cancer drug resistance. Strategically regulating MV release may increase drug retention within cancer cells and allow for lower doses of chemotherapeutic drugs. The contribution of exosomes to drug retention still...
Autores principales: | Kosgodage, Uchini S., Trindade, Rita P., Thompson, Paul R., Inal, Jameel M., Lange, Sigrun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454920/ https://www.ncbi.nlm.nih.gov/pubmed/28486412 http://dx.doi.org/10.3390/ijms18051007 |
Ejemplares similares
-
Peptidylarginine Deiminases—Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release?
por: Lange, Sigrun, et al.
Publicado: (2017) -
Cannabidiol (CBD) Is a Novel Inhibitor for Exosome and Microvesicle (EMV) Release in Cancer
por: Kosgodage, Uchini S., et al.
Publicado: (2018) -
Peptidylarginine Deiminase Inhibitors Reduce Bacterial Membrane Vesicle Release and Sensitize Bacteria to Antibiotic Treatment
por: Kosgodage, Uchini S., et al.
Publicado: (2019) -
Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
por: Kosgodage, Uchini S., et al.
Publicado: (2018) -
A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy
por: Kholia, Sharad, et al.
Publicado: (2015)